Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Karrison

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Blood Cancer Journal|May 29, 2024
Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplantBenjamin A Derman, Jennifer Cooperrider, Jacalyn Rosenblatt, et al.
Cancer Research|November 20, 2002
Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinomaS Diane Yamada, Jonathan A Hickson, Yancey Hrobowski, et al.
Journal of Visualized Experiments : Jove|February 10, 2011
Generation of comprehensive thoracic oncology database--tool for translational researchMosmi Surati, Matthew Robinson, Suvobroto Nandi, et al.
Cancer|April 21, 2021
A prospective clinical and transcriptomic feasibility study of oral-only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidityBenjamin E Onderdonk, Paige L Dorn, Carlos Martinez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate CancerAnthony V Serritella, Daniel Shevrin, Elisabeth I Heath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2004
Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecanFederico Innocenti, Samir D Undevia, Lalitha Iyer, et al.
Oncogene|April 13, 2004
Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumorsKarin Schreiber, Ronald E Cannon, Theodore Karrison, et al.
Scientia Medica|May 12, 2012
Chorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago-based, Congenital Toxoplasmosis StudyA Gwendolyn Noble, Paul Latkany, Jaroslaw Kusmierczyk, et al.
Cancer|February 2, 2019
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2James K Godfrey, Chadi Nabhan, Theodore Karrison, et al.
Annals of Translational Medicine|June 24, 2024
FLT3 inhibitor maintenance after allogeneic stem cell transplantation in <i>FLT3</i>-mutated acute myeloid leukemia (AML) patientsGong He, Erika Belmont, Theodore Karrison, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Blood Cancer Journal|May 29, 2024
Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplantBenjamin A Derman, Jennifer Cooperrider, Jacalyn Rosenblatt, et al.
Cancer Research|November 20, 2002
Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinomaS Diane Yamada, Jonathan A Hickson, Yancey Hrobowski, et al.
Journal of Visualized Experiments : Jove|February 10, 2011
Generation of comprehensive thoracic oncology database--tool for translational researchMosmi Surati, Matthew Robinson, Suvobroto Nandi, et al.
Cancer|April 21, 2021
A prospective clinical and transcriptomic feasibility study of oral-only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidityBenjamin E Onderdonk, Paige L Dorn, Carlos Martinez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate CancerAnthony V Serritella, Daniel Shevrin, Elisabeth I Heath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2004
Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecanFederico Innocenti, Samir D Undevia, Lalitha Iyer, et al.
Oncogene|April 13, 2004
Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumorsKarin Schreiber, Ronald E Cannon, Theodore Karrison, et al.
Scientia Medica|May 12, 2012
Chorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago-based, Congenital Toxoplasmosis StudyA Gwendolyn Noble, Paul Latkany, Jaroslaw Kusmierczyk, et al.
Cancer|February 2, 2019
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2James K Godfrey, Chadi Nabhan, Theodore Karrison, et al.
Annals of Translational Medicine|June 24, 2024
FLT3 inhibitor maintenance after allogeneic stem cell transplantation in <i>FLT3</i>-mutated acute myeloid leukemia (AML) patientsGong He, Erika Belmont, Theodore Karrison, et al.
Pageof 16